BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 138 filers reported holding BIOLIFE SOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,290 | -37.5% | 9,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $198,900 | +1.6% | 9,000 | 0.0% | 0.01% | +20.0% |
| Q1 2023 | $195,750 | +19.4% | 9,000 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $164,000 | -20.0% | 9,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $205,000 | +65.3% | 9,000 | 0.0% | 0.01% | +100.0% |
| Q2 2022 | $124,000 | -39.5% | 9,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $205,000 | -38.8% | 9,000 | 0.0% | 0.00% | -42.9% |
| Q4 2021 | $335,000 | -12.1% | 9,000 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $381,000 | -5.0% | 9,000 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $401,000 | +23.8% | 9,000 | 0.0% | 0.01% | +28.6% |
| Q1 2021 | $324,000 | -9.7% | 9,000 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $359,000 | +38.1% | 9,000 | 0.0% | 0.01% | +12.5% |
| Q3 2020 | $260,000 | +76.9% | 9,000 | 0.0% | 0.01% | +60.0% |
| Q2 2020 | $147,000 | +72.9% | 9,000 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $85,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |